天目药业
(600671)
| 流通市值：16.51亿 | | | 总市值：16.51亿 |
| 流通股本：1.22亿 | | | 总股本：1.22亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 33,246,867.03 | 65,724,985.87 | 30,426,181.81 | 71,310,865.17 |
| 应收票据及应收账款 | 112,145,182.52 | 96,565,118.72 | 64,035,560.53 | 31,473,384.29 |
| 应收账款 | 112,145,182.52 | 96,565,118.72 | 64,035,560.53 | 31,473,384.29 |
| 应收款项融资 | 173,335.87 | 1,409,127.44 | - | 1,352,778.33 |
| 预付款项 | 7,411,332.89 | 2,295,767.16 | 6,289,813.4 | 6,427,641.89 |
| 其他应收款合计 | 2,004,304.08 | 2,562,954.67 | 2,091,933.73 | 2,350,435.93 |
| 存货 | 57,081,131.9 | 52,323,040.59 | 46,732,499.13 | 53,217,485.84 |
| 其他流动资产 | 1,446,359.33 | 1,832,699.27 | 729,272.98 | 1,330,517.44 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 217,008,513.62 | 222,713,693.72 | 150,305,261.58 | 167,463,108.89 |
| 非流动资产: | | | | |
| 固定资产 | 163,682,467.6 | 167,026,123.77 | 166,998,592.65 | 134,817,067.98 |
| 在建工程 | 1,831,487.52 | 1,253,350.94 | 970,325.48 | 5,527,433.9 |
| 使用权资产 | 22,669,615.33 | 24,577,269.91 | 26,578,457.39 | 11,423,407.55 |
| 无形资产 | 5,049,312.21 | 5,088,010.11 | 5,126,708.01 | 5,165,405.91 |
| 商誉 | 1,614,611.74 | 1,614,611.74 | 2,198,559.52 | 2,198,559.52 |
| 长期待摊费用 | 11,180,526.76 | 12,053,763.24 | 10,561,595.14 | 3,141,304.63 |
| 递延所得税资产 | 7,182,984.38 | 7,136,414.26 | 3,611,799.02 | 3,411,936.7 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 213,211,005.54 | 218,749,543.97 | 216,046,037.21 | 165,685,116.19 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 430,219,519.16 | 441,463,237.69 | 366,351,298.79 | 333,148,225.08 |
| 流动负债: | | | | |
| 短期借款 | 124,824,940 | 126,886,706.77 | 87,450,000 | 72,565,186.04 |
| 应付票据及应付账款 | 83,478,663.56 | 88,629,705.78 | 85,793,667.99 | 69,871,271.9 |
| 其中：应付票据 | 8,951,357.65 | 6,388,763.05 | 15,923,890.37 | 19,034,617.06 |
| 应付账款 | 74,527,305.91 | 82,240,942.73 | 69,869,777.62 | 50,836,654.84 |
| 合同负债 | 4,392,383.84 | 2,454,063.03 | 3,574,371.79 | 2,764,522.46 |
| 应付职工薪酬 | 2,999,217.92 | 3,909,658.31 | 4,007,252.52 | 4,476,112.2 |
| 应交税费 | 14,407,384.25 | 15,659,645.82 | 8,473,623.4 | 1,420,735.85 |
| 其他应付款合计 | 29,871,753.1 | 35,042,667.86 | 37,237,357.1 | 70,770,621.19 |
| 应付股利 | 23,403.36 | 23,403.36 | 23,403.36 | 23,403.36 |
| 一年内到期的非流动负债 | 10,410,354.4 | 13,570,923.12 | 3,316,726.6 | 4,096,263.58 |
| 其他流动负债 | 537,607.85 | 228,910.31 | 460,766.45 | 358,634.32 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 270,922,304.92 | 286,382,281 | 230,313,765.85 | 226,323,347.54 |
| 非流动负债: | | | | |
| 租赁负债 | 13,131,763.29 | 10,335,472.84 | 21,327,754.79 | 6,298,239.95 |
| 预计负债 | 948,080.59 | 948,080.59 | - | 83,326.32 |
| 递延收益 | 51,140,027.29 | 52,634,184.46 | 55,420,336.6 | 56,452,592.99 |
| 递延所得税负债 | 6,117,678.86 | 6,144,317.49 | 2,779,061.18 | 2,855,851.88 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 71,337,550.03 | 70,062,055.38 | 79,527,152.57 | 65,690,011.14 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 342,259,854.95 | 356,444,336.38 | 309,840,918.42 | 292,013,358.68 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 121,778,885 | 121,778,885 | 121,778,885 | 121,778,885 |
| 资本公积 | 162,787,915.98 | 162,787,915.98 | 162,787,915.98 | 162,787,915.98 |
| 盈余公积 | 24,181,414.37 | 24,181,414.37 | 24,181,414.37 | 24,181,414.37 |
| 未分配利润 | -251,270,022.51 | -256,364,330.55 | -275,305,704.34 | -290,110,887.23 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 57,478,192.84 | 52,383,884.8 | 33,442,511.01 | 18,637,328.12 |
| 少数股东权益 | 30,481,471.37 | 32,635,016.51 | 23,067,869.36 | 22,497,538.28 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 87,959,664.21 | 85,018,901.31 | 56,510,380.37 | 41,134,866.4 |
| 负债和股东权益合计 | 430,219,519.16 | 441,463,237.69 | 366,351,298.79 | 333,148,225.08 |
| 公告日期 | 2025-04-28 | 2025-04-01 | 2024-10-30 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |